Ciclopirox 1% shampoo is a safe and effective treatment for seborrheic dermatitis

International Journal of Dermatology

Volumn 43, Issue SUPPL. 1, 2004, Pages 1-2

  Gupta, Aditya K ^a,b,d   Lebwohl, Mark ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MEDIPROBE RESEARCH INC   (Canada)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CICLOPIROX; SHAMPOO;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; HUMAN; MALASSEZIA; NONHUMAN; SEBORRHEIC DERMATITIS;

EID: 4444332500     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1461-1244.2004.02383.x     Document Type: Editorial

References (4)

1. Gupta AK, Plott T. Ciclopirox: a broad-spectrum antifungal with antibacterial and anti-inflammatory properties. Int J Dermatol 2004; 43 (Suppl. 1): 3-8.
2. Altmeyer P. Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial. Int J Dermatol 2004; 43 (Suppl. 1): 9-12.
3. Abeck D. Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage. Int J Dermatol 2004; 43 (Suppl. 1): 13-16.
4. Lebwohl M, Plott T. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial. Int J Dermatol 2004; 43 (Suppl. 1): 17-20.